AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback